I am a
Home I AM A Search Login

Papers of the Week

2020 Jan

Int J Colorectal Dis



Efficacy of Saccharomyces cerevisiae CNCM I-3856 as an add-on therapy for irritable bowel syndrome.


Gayathri R, Aruna T, Malar S, Shilpa B, Dhanasekar K R
Int J Colorectal Dis. 2020 Jan; 35(1):139-145.
PMID: 31807856.


The symptoms of irritable bowel syndrome (IBS) lead to considerable impairment of health-related quality of life and high health care costs. Available therapies are not efficient in treating the symptoms of IBS. Studies have shown the beneficial effects of Saccharomyces cerevisiae CNCM I-3856. Therefore, this study was done to evaluate the efficacy and safety of S. cerevisiae CNCM I-3856 in the treatment of IBS.